drugset
drugset / Trial / NCT05083468

The Safety, Tolerability, and Pharmacokinetics (PK) of SR750 in Healthy Volunteers

NCT05083468 ↗

Phase 1 Completed 83 enrolled Shanghai SIMR Biotechnology Co., Ltd.
RandomizedSequentialTriple-blindTreatment

Summary

This study is to evaluate the safety, tolerability, and PK of SR750 in healthy volunteers.

Timeline

Start
2021-10-29
Primary completion
2022-10-14
Completion
2022-10-14

Drugs

EvaluationDrugModalityDoseRoute
Subject SR750 Unknown — Oral

Indications

No indication recorded.